Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1532-1538

  Scholz, Christian ^a,c,e   Patton, Kurt T ^a   Anderson, David E ^a,c   Freeman, Gordon J ^b   Hafler, David A ^a,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; TETANUS TOXOID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; HELPER CELL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; AUTOANTIGENS; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTE SUBSETS; TETANUS TOXOID; THYMIDINE;

EID: 0031892792     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Prineas, J. W., and C. S. Raine. 1976. Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurology 26:29.
2. Prineas, J. W., and R. G. Wright. 1978. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38:409.
3. Adams, C. W., R. N. Poston, and S. J. Buk. 1989. Pathology, histochemstry and immunocytochemistry of lesions in acute multiple sclerosis. J. Natural Sci. 92:291.
4. Zamvil, S. S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyetitis. Annu. Rev. Immunol. 8:579.
5. Jenkins, M. K., J. D. Ashwell, and R. H. Schwartz. 1988. Allogenic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140:3324.
6. Jenkins, M. K., C. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz. 1990. Inhibition of antigen specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16.
7. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
8. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig Superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
9. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87:5031.
10. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 is a second ligand for CTLA-4 and CD28. Nature 366:76.
11. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
12. Gimmi, C., G. Freeman, J. Gribben, G. Gray, and L. Nadler. 1993. Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Nat. Acad. Sci USA 90:6586.
13. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. D. Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 Interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
14. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80:707.
15. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
16. Williams, K. E., E. Ulvestad, and J. P. Antel. 1994. B7/BB-1 antigen expression on adult human microglia studies in vitro and in situ. Eur. J. Immunol. 24:3031.
17. Marrack, P., A. Hermann, J. W. Kappler, and A. M. Pullen. 1991. Superantigens: mechanisms of T cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745.
18. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
19. + T cells differing in CD45R expression. J. Immunol. 149:2300.
20. Ronchese, F., and B. Hausmann. 1993. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 177:679.
21. Croft, M., L. M. Bradley, and S. L. Swain. 1994. Naive versus memory CD4 T cell responses to antigen. J. Immunol. 152:2675.
22. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of IL-2 responsive T cells specific for myelin basic protein (MBP) and proteolipid protein (PLP) in peripheral blood and cerebrospinal fluid (CSF) of patients with multiple sclerosis. J. Exp. Med. 179:973.
23. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T cell autoimmunity to cryptic determinants of autoantigen. Nature 358:155.
24. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
25. Fukaura, H., S. C. Kent, M. J. Pietrusewicz, S. J. Khoury, H. L. Weiner, and D. A. Hafler. 1996. Induction of circulating myelin basic protein and proteolipid protein specific TGF-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:70.
26. Martin, R., M. D. Howell, D. Jaraquemada, M. Flerlage, J. Richert, S. Brostoff, E. O. Long, D. E. McFarlin, and H. F. McFarland. 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:19.
27. Pette, M., K. Fujita, D. Wilkinson, D. M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J. T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphoctyes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. 87:7968.
28. Allegretta, M., J. A. Nicklas, S. Sriram, and R. J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718.
29. Valli, A., A. Sette, L. Kappos, C. Oseroff, J. Sidney, G. Miescher, M. Hochberger, E. D. Albert, and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Inves. 91:616.
30. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
31. Bieganowska, K., L. Ausubel, Y. Modabber, E. Slovik, W. Messersmith, and D. Hafler. 1997. Direct ex vivo analysis of activated, fas-sensitive autoreactive T cells in human autoimmune disease. J. Exp. Med. 185:1585.
32. Höllsberg, P., C. Scholz, D. Anderson, E. Greenfield, V. Kuchroo, G. Freeman, and D. Hafler. 1997. Expression of a hypoglycolylated form of CD86 (B7-2) on human T cells with altered binding properties to cD28 and CTLA-4. J. Immunol. 159:4799.
33. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Röcken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune diseases. J. Exp. Med. 180:1961.